Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Hybrid Fractional Laser Treatment for Symptoms of Genitourinary Syndrome of Menopause

NCT03178825 is registered in ClinicalTrials.gov with Sciton as lead sponsor.

NCT NCT03178825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03178825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Hybrid Fractional Laser Treatment for Symptoms of Genitourinary Syndrome of Menopause
Lead sponsor
Sciton
Phase
Not applicable
Overall status
Completed
Start date
May 19, 2017
Completion date
February 25, 2020
Enrollment
60 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic uti, dyspareunia, sexual dysfunction, vaginal atrophy, vaginal dryness